Heterocycles via intramolecular platinum-catalyzed propargylic substitution

Tetrahedron

Volumn 67, Issue 27-28, 2011, Pages 5046-5053

  Liang, Qiren ^a   De Brabander, Jef K ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Dioxanes; Morpholines; Platinum catalysis; Propargylic substitution; Sulfamates; Tetrahydropyrans

Indexed keywords

2 (4 HEX 1 YN 1 YL) 1,4 DIOXANE; 2 (4 OCTBUT 1 YN 1 YL) 1,4 DIOXANE; 2 (4 PHENYLBUT 1 YN 1 YL) 1,4 DIOXANE; 2 (OCT 1 YN 1 YL) 6 PHENYL 1,4 DIOXANE; 2 (PHENYLETHYL) 1,4 DIOXANE; 2 ETHYL 6 (HEX 1 YN 1 YL) 1,4 DIOXANE; 2 ETHYL 6 (OCT 1 YN 1 YL) 1,4 DIOXANE; 2 PHENYL 6 (PHENYLETHYL) 1,4 DIOXANE; 3 (4 PHENYLBUT 1 YN 1 YL) 4 TOSYLMORPHOLINE; 3 (HEX 1 YN 1 YL) 4 TOSYLMORPHOLINE; 3 (OCT 1 YN 1 YL) 4 TOSYLMORPHOLINE; 3 (PHENYLETHYNYL) 4 TOSYLMORPHOLINE; ALKYNE DERIVATIVE; DIOXANE; HETEROCYCLIC COMPOUND; MORPHOLINE; NUCLEOPHILE; PLATINUM; PROPARGYLIC ACETATE; SULFAMIC ACID; SULFUR DERIVATIVE; TERT BUTYL 2 (4 PHENYLBUT 1 YN 1 YL)MORPHOLINE 4 CARBOXYLATE; TERT BUTYL 2 (OCT 1 YN 1 YL)MORPHOLINE 4 CARBOXYLATE; TERT BUTYL 2 (PHENYLETHYL)MORPHOLINE 4 CARBOXYLATE; TERT BUTYL 2 ETHYL 6 (4 PHENYLBUT 1 YN 1 YL)MORPHOLINE 4 CARBOXYLATE; TERT BUTYL 2 ETHYL 6 (OCT 1 YN 1 YL)MORPHOLINE 4 CARBOXYLATE; TERT BUTYL 2 ISOPROPYL 6 (4 PHENYLBUT 1 YN 1 YL)MORPHOLINE 4 CARBOXYLATE; TERT BUTYL 2 PHENYL 6 (4 PHENYLBUT 1 YN 1 YL)MORPHOLINE 4 CARBOXYLATE; TERT BUTYL 2 PHENYL 6 (PHENYLETHYL)MORPHOLINE 4 CARBOXYLATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CATALYSIS; CYCLIZATION; DRUG SYNTHESIS; MOLECULAR INTERACTION; PRIORITY JOURNAL; SUBSTITUTION REACTION;

EID: 79958695955     PISSN: 00404020     EISSN: 14645416     Source Type: Journal    
DOI: 10.1016/j.tet.2011.03.115     Document Type: Article

References (59)

1. For selected reviews and examples see: (a) Kumar, K.; Waldmann, H. Angew. Chem., Int. Ed. 2009, 48, 3224-3242;
2. (b) Nicolaou, K. C.; Chen, J. S. Pure Appl. Chem. 2008, 80, 727-742;
3. (c) Elliot, M. C. J. Chem. Soc., Perkin Trans. 1 2000, 1291-1318;
4. (d) Sromek, A. W.; Kel'in, A. V.; Gevorgyan, V. Angew. Chem., Int. Ed. 2004, 43, 2280-2282;
5. (e) Zhang, L. J. Am. Chem. Soc. 2005, 127, 16804-16805.
6. (a) De Brabander, J. K.; Liu, B.; Qian, M. Org. Lett. 2008, 10, 2533-2536;
7. (b) For a cycloisomerization strategy towards spiroketals, tetrahydrofuranyl, and tetrahydropyranyl acetals from our laboratory, see: Liu, B.; De Brabander, J. K. Org. Lett. 2006, 8, 4907-4910.
8. In an important precedent, it was demonstrated that replacement of the tetrahydropyran B-ring of the bryostatins with a dioxane heterocycle not only significantly improved synthetic access, but also provided analogs with equal or superior biological activity, see: Wender, P. A.; DeBrabander, J.; Harran, P. G.; Jimenez, J.-M.; Koehler, M. F. T.; Lippa, B.; Park, C.-M.; Shiozaki, M. J. Am. Chem. Soc. 1998, 120, 4534-4535.
9. (a) Fish, P. V.; Deur, G.; Gan, X.; Greene, K.; Hoople, D.; Mackenny, M.; Para, K. S.; Reeves, K.; Ryckmans, T.; Stiff, C.; Stobie, A.; Wakenhut, F.; Whitlock, G. A. Bioorg. Med. Chem. Lett. 2008, 18, 2562-2566;
10. (b) Kelley, J. L.; Musso, D. L.; Boswell, G. E.; Soroko, F. E.; Cooper, B. R. J. Med. Chem. 1996, 39, 347-349.
11. Kuettel, S.; Zambon, A.; Kaiser, M.; Brun, R.; Scapozza, L.; Perozzo, R. J. Med. Chem. 2007, 50, 5833-5839.
12. (a) Allison, B. D.; Phuong, V. K.; McAtee, L. C.; Rosen, M.; Morton, M.; Prendergast, C.; Barrett, T.; Lagaud, G.; Freedman, J.; Li, L.; Wu, X.; Venkatesan, H.; Pippel, M.; Woods, C.; Rizzolio, M. C.; Hack, M.; Hoey, K.; Deng, X.; King, C.; Shankley, N. P.; Rabinowitz, M. H. J. Med. Chem. 2006, 49, 6371-6390;
13. (b) Kim, D. K.; Ryu, D. H.; Lee, J. Y.; Lee, N.; Kim, Y.W.; Kim, J. S.; Chang, K.; Im, G. J.; Kim, T. K.; Choi, W. S. J. Med. Chem. 2001, 44, 1594-1602;
14. (c) Acton, E. M.; Tong, G. L.; Mosher, C. W.; Wolgemuth, R. L. J. Med. Chem. 1984, 27, 638-640.
15. Chrysselis, M. C.; Rekka, E. A.; Siskou, I. C.; Kourounakis, P. N. J. Med. Chem. 2002, 45, 5406-5409.
16. Hale, J. J.; Mills, S. G.; MacCoss, M.; Shah, S. K.; Qi, H.; Mathre, D. J.; Cascieri, M. A.; Sadowski, S.; Strader, C. D.; MacIntyre, D. E.; Metzger, J. M. J. Med. Chem. 1996, 39, 1760-1762.
17. Letnicer, D. Organic Chemistry of Drug Synthesis; Wiley: New York, NY, 2008; Vol. 7.
18. (a) Pettigrew, J. D.; Freeman, R. R.; Wilson, P. D. Can. J. Chem. 2004, 82,1640-1648;
19. (b) Dave, R.; Sasaki, N. A. Tetrahedron: Asymmetry 2006, 17, 388-401.
20. For selected recent examples, see: (a) Bandini, M.; Monari, M.; Romaniello, A.; Tragni, M. Chem. - Eur. J. 2010, 16, 14272-14277;
21. (b) Leathen, M. L.; Rosen, B. R.; Wolfe, J. P. J. Org. Chem. 2009, 74, 5107-5110;
22. (c) Nonnenmacher, J.; Grellepois, F.; Portella, C. Eur. J. Org. Chem. 2009, 3726-3731;
23. (d) Yar, M.; McGarrigle, E. M.; Aggarwal, V. K. Org. Lett. 2009, 11, 257-260;
24. (e) Breuning, M.; Hein, D.; Steiner, M.; Gessner, V. H.; Strohmann, C. Chem. - Eur. J. 2009, 15, 12764-12769;
25. (f) Penso, M.; Lupi, V.; Albanese, D.; Foschi, F.; Landini, D.; Tagliabue, A. Synlett 2008, 2451-2454;
26. (g) Leijondahl, K.; Boren, L.; Braun, R.; Bäckvall, J.-E. Org. Lett. 2008, 10, 2027-2030;
27. (h) Wilkinson, M. C.; Bell, R.; Landon, R.; Nikiforov, P. O.; Walker, A. J. Synlett 2006, 2151-2153;
28. (i) D'hooghe, M. D.; Vanlangendonck, T.; Törnroos, K. W.; De Kimpe, N. J. Org. Chem. 2006, 71, 4678-4681;
29. (j) Lanman, B. A.; Myers, A. G. Org. Lett. 2004, 6, 1045-1047;
30. (k) Dave, R.; Sasaki, N. A. Org. Lett. 2004, 6, 15-18;
31. (l) Grotenberg, G. M.; Christina, A. E.; Buizert, A. E. M.; van der Marel, G. A.; Overkleeft, H. S.; Overhead, M. J. Org. Chem. 2004, 69, 8331-8339;
32. (m) Tiecco, M.; Testaferri, L.; Marini, F.; Sternativo, S.; Santi, C.; Bagnoli, L.; Temperini, A. Tetrahedron: Asymmetry 2003, 14, 2651-2657;
33. (n) Takahata, H.; Takahashi, S.; Kouno, S.-i.; Momose, T. J. Org. Chem. 1998, 63, 2224-2231;
34. (o) Lai, J.-Y.; Shi, X.-X.; Gong, Y.-S.; Dai, L.-X. J. Org. Chem. 1993, 58, 4775-4777.
35. For a review see: Wijtmans, R.; Vink, M. K. S.; Schoemaker, H. E.; van Delft, F. L.; Blaauw, R. H.; Rutjes, F. P. J. T. Synthesis 2004, 641-662.
36. See the Supplementary data for details.
37. For a detailed study on propargylic ester/allenyl ester epimerization, see: Schlossarczyk, H.; Sieber, W.; Hesse, M.; Hansen, H.-J.; Scmid, H. Helv. Chim. Acta 1973, 56, 875-944.
38. As for all propargylic substitutions reported herein, diastereomeric mixtures of starting materials (equimolar ratios) always converged to single diastereomeric products via a dynamic kinetic resolution. See Eq. 1 for a potential mechanism for epimerization at the propargylic center.
39. Correa, A.; Marion, N.; Fensterbank, L.; Malacria, M.; Nolan, S. P.; Cavallo, L. Angew. Chem., Int. Ed. 2008, 47, 718-721.
40. N-Boc-protected amines were not effective substrates.
41. Aubè, J.; Mossman, C. J.; Dickey, S. Tetrahedron 1992, 48, 9819-9826.
42. Concellón, J. M.; Bernad, P. L.; del Solar, V.; García-Grandam, S.; Díaz, M. R. Adv. Synth. Catal. 2008, 350, 477-481.
43. Tiecco, M.; Testaferri, L.; Marini, F.; Sternativo, S.; Santi, C.; Bagnoli, L.; Temperini, A. Tetrahedron: Asymmetry 2003, 14, 1095-1102.
44. Braun, A.; Toupet, L.; Lellouche, J.-P. J. Org. Chem. 1996, 61, 1914-1915.
45. Takekawa, I.; Nukata, H.; Nakamura, H.; Miyamoto, M. Japanese Patent 10,265,564, 1998;
46. Chem. Abstr. 1998, 129, 337617.
47. Conrad, J.; Schaper, U. A.; Bruns, K. German Patent 2,629,000, 1978;
48. Chem. Abstr. 1978, 89, 80129.
49. Lee, J. Y.; Park, Y. K.; Seo, S. H.; Yang, B. S.; Park, H.; Lee, Y. S. Arch. Pharmacol. 2002, 335, 487-494.
50. Kim, H. Y.; Kuhn, R. J.; Patkar, C.; Warrier, R.; Cushman, M. Bioorg. Med. Chem. 2007, 15, 2667-2679.
51. (a) Piergentili, A.; Quaglia, W.; Giannella, M.; Del Bello, F.; Bruni, B.; Buccioni, M.; Carrieri, A.; Ciattini, S. Bioorg. Med. Chem. 2007, 15, 886-896;
52. (b) Tarselli, M. A.; Zuccarello, J. L.; Lee, S. J.; Gagné, M. R. Org. Lett. 2009, 11, 3490-3492;
53. (c) Quaglia, W.; Piergentili, A.; Del Bello, F.; Farande, Y.; Giannella, M.; Pigini, M.; Rafaiani, G.; Carrieri, A.; Amantini, C.; Lucciarini, R.; Santoni, G.; Poggesi, E.; Leonardi, A. J. Med. Chem. 2008, 51, 6359-6370.
54. Dauban, P.; Dodd, R. H. Tetrahedron Lett. 2001, 42, 1037-1040.
55. Wehn, P. M.; Du Bois, J. Org. Lett. 2005, 7, 4685-4688.
56. Fleming, J. J.; McReynolds, M. D.; Du Bois, J. J. Am. Chem. Soc. 2007, 129, 9964-9975.
57. Wang, Y.-Q.; Yu, C.-B.; Wang, D.-W.; Wang, X.-B.; Zhou, Y.-G. Org. Lett. 2008, 10, 2071-2074.
58. Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925.
59. Gottlieb, H. E.; Kotlyar, V.; Nudelman, A. J. Org. Chem. 1997, 62, 7512-7515.